PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 10 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Clinical evidence
Oral administration of yerba buena produced analgesic efficacy comparable to Paracetamol [PMID:39758304].
In vitro testing of Mentha arvensis leaf extracts showed reduced viral infectivity, with the ethanol extract decreasing plaque numbers by 62% relative to control [PMID:35367996].
In vitro and in vivo studies demonstrated antihypertensive, antibacterial, anthelmintic, antitumor, antiviral, and analgesic activities [PMID:39758304].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 39758304 (2024) — Pharmacologic Activities of Yerba Buena (Mentha x villosa Huds Fam. Lamiaceae): An Overview. · Acta medica Philippina
- 2.PMID: 10330066 (1999) — Shade-avoidance responses in two common coastal redwood forest species, Sequoia sempervirens (Taxodiaceae) and Satureja douglasii (Lamiaceae), occurring in various light quality environments. · American journal of botany
- 3.PMID: 35367996 (2021) — A Preliminary Investigation on the Antiviral Activities of the Philippine Marshmint (Mentha arvensis) Leaf Extracts against Dengue Virus Serotype 2 In Vitro. · The Kobe journal of medical sciences